- Home
- STRRP vs VCEL Comparison
STRRP vs VCEL Comparison
Compare STRRP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRRP
- VCEL
- Stock Information
- Founded
- STRRP N/A
- VCEL 1989
- Country
- STRRP United States
- VCEL United States
- Employees
- STRRP 194
- VCEL N/A
- Industry
- STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STRRP Health Care
- VCEL Health Care
- Exchange
- STRRP Nasdaq
- VCEL Nasdaq
- Market Cap
- STRRP N/A
- VCEL 2.1B
- IPO Year
- STRRP N/A
- VCEL 1997
- Fundamental
- Price
- STRRP $9.23
- VCEL $39.98
- Analyst Decision
- STRRP
- VCEL Strong Buy
- Analyst Count
- STRRP 0
- VCEL 8
- Target Price
- STRRP N/A
- VCEL $62.00
- AVG Volume (30 Days)
- STRRP N/A
- VCEL 476.9K
- Earning Date
- STRRP N/A
- VCEL 07-31-2025
- Dividend Yield
- STRRP N/A
- VCEL N/A
- EPS Growth
- STRRP N/A
- VCEL 521.85
- EPS
- STRRP N/A
- VCEL 0.05
- Revenue
- STRRP N/A
- VCEL $238,541,000.00
- Revenue This Year
- STRRP N/A
- VCEL $23.03
- Revenue Next Year
- STRRP N/A
- VCEL $24.52
- P/E Ratio
- STRRP N/A
- VCEL $675.02
- Revenue Growth
- STRRP N/A
- VCEL 14.80
- 52 Week Low
- STRRP N/A
- VCEL $37.39
- 52 Week High
- STRRP N/A
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- STRRP 55.70
- VCEL 42.08
- Support Level
- STRRP $9.01
- VCEL $39.39
- Resistance Level
- STRRP $9.29
- VCEL $42.61
- Average True Range (ATR)
- STRRP 0.03
- VCEL 1.61
- MACD
- STRRP 0.03
- VCEL -0.20
- Stochastic Oscillator
- STRRP 82.86
- VCEL 11.60
About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.